Joy MS - Search Results

1

Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study.

Lionaki S, Hogan SL, Falk RJ, Joy MS, Chin H, Jennette CE, Jennette JC, Nachman PH. Lionaki S, et al. Among authors: joy ms. Nephrol Dial Transplant. 2007 Dec;22(12):3508-15. doi: 10.1093/ndt/gfm493. Epub 2007 Aug 8. Nephrol Dial Transplant. 2007. PMID: 17686815

2

A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis.

Joy MS, Hogan SL, Jennette JC, Falk RJ, Nachman PH. Joy MS, et al. Nephrol Dial Transplant. 2005 Dec;20(12):2725-32. doi: 10.1093/ndt/gfi117. Epub 2005 Sep 27. Nephrol Dial Transplant. 2005. PMID: 16188901

3

Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity.

Joy MS, Hogan SL, Thompson BD, Finn WF, Nickeleit V. Joy MS, et al. Nephrol Dial Transplant. 2007 Jul;22(7):1963-8. doi: 10.1093/ndt/gfm133. Epub 2007 Mar 29. Nephrol Dial Transplant. 2007. PMID: 17395652

4

Vasculitis and anti-thyroid medication.

Lionaki S, Hogan SL, Falk RJ, Joy MS, Jennette CE, Nachman PH, Jennette JC. Lionaki S, et al. Among authors: joy ms. Nephrol Dial Transplant. 2008 May;23(5):1766-8; author reply 1768. doi: 10.1093/ndt/gfm887. Epub 2007 Dec 21. Nephrol Dial Transplant. 2008. PMID: 18424466 Free PMC article. No abstract available.

5

Influence of clinical and demographic variables on mycophenolic acid pharmacokinetics in antineutrophil cytoplasmic antibody-associated vasculitis.

Joy MS, Hilliard T, Hu Y, Hogan SL, Wang J, Falk RJ, Smith PC. Joy MS, et al. Ann Pharmacother. 2009 Jun;43(6):1020-7. doi: 10.1345/aph.1L699. Epub 2009 Jun 2. Ann Pharmacother. 2009. PMID: 19491317 Free PMC article. Clinical Trial.

6

Cutaneous and systemic manifestations of drug-induced vasculitis.

ten Holder SM, Joy MS, Falk RJ. ten Holder SM, et al. Among authors: joy ms. Ann Pharmacother. 2002 Jan;36(1):130-47. doi: 10.1345/aph.1A124. Ann Pharmacother. 2002. PMID: 11816242 Review.

7

Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease.

Joy MS, Candiani C, Vaillancourt BA, Chin H, Hogan SL, Falk RJ. Joy MS, et al. Pharmacotherapy. 2007 May;27(5):734-44. doi: 10.1592/phco.27.5.734. Pharmacotherapy. 2007. PMID: 17461709

8

Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis.

Joy MS, Boyette T, Hu Y, Wang J, La M, Hogan SL, Stewart PW, Falk RJ, Dooley MA, Smith PC. Joy MS, et al. Eur J Clin Pharmacol. 2010 Nov;66(11):1119-30. doi: 10.1007/s00228-010-0846-x. Epub 2010 Jun 22. Eur J Clin Pharmacol. 2010. PMID: 20567810 Free PMC article.

9

Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis.

Joy MS, La M, Wang J, Bridges AS, Hu Y, Hogan SL, Frye RF, Blaisdell J, Goldstein JA, Dooley MA, Brouwer KL, Falk RJ. Joy MS, et al. Br J Clin Pharmacol. 2012 Sep;74(3):445-55. doi: 10.1111/j.1365-2125.2012.04223.x. Br J Clin Pharmacol. 2012. PMID: 22380717 Free PMC article. Clinical Trial.

10

Long-term glycemic control measurements in diabetic patients receiving hemodialysis.

Joy MS, Cefalu WT, Hogan SL, Nachman PH. Joy MS, et al. Am J Kidney Dis. 2002 Feb;39(2):297-307. doi: 10.1053/ajkd.2002.30549. Am J Kidney Dis. 2002. PMID: 11840370 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters